Virus Protease

病毒蛋白酶 (Virus Protease) 是由病毒病原体的遗传物质(DNA 或 RNA)编码的酶。病毒蛋白酶催化病毒多聚蛋白前体或细胞蛋白中特定肽键的裂解。病毒蛋白酶可能使用涉及丝氨酸、半胱氨酸或天冬氨酸残基的不同催化机制来攻击易断裂的肽键。酶的互补底物结合位点对这些序列模式的选择性识别可确保高度特异性的识别和裂解。

严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 是呼吸道疾病冠状病毒病 2019 (COVID-19) 的病因。跨膜蛋白酶丝氨酸 2 (TMPRSS2) 的初始刺突蛋白启动对于 SARS-CoV-2 的进入至关重要。SARS-CoV-2 病毒体附着到靶细胞后,细胞的蛋白酶 TMPRSS2 会切开病毒的刺突蛋白,从而暴露出融合肽。

Viral proteases are enzymes encoded by the genetic material (DNA or RNA) of viral pathogens. Viral proteases catalyze the cleavage of specific peptide bonds in viral polyprotein precursors or in cellular proteins. Viral proteases may use different catalytic mechanisms involving either serine, cysteine or aspartic acid residues to attack the scissile peptide bond. Selective recognition of these sequence patterns by a complementary substrate binding site of the enzyme ensures a high degree of specific recognition and cleavage.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the cause of the respiratory illness coronavirus disease 2019 (COVID-19). Initial spike protein priming by transmembrane protease, serine 2 (TMPRSS2) is essential for entry of SARS-CoV-2. After a SARS-CoV-2 virion attaches to a target cell, the cell's protease TMPRSS2 cuts open the spike protein of the virus, exposing a fusion peptide.

共 2种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
Mergocriptine
CBM36-733

Mergocriptine (CBM36-733) 是一种多巴胺受体 (dopamine receptor) 激动剂和 SARS-CoV-2 Mpro 配体,可调节步行活动。

81968-16-3
Ligand
Mergocriptine
SARS-CoV-2 Mpro ligand 2

SARS-CoV-2 Mpro ligand 2(Compound 24)是一种靶向 PROTAC 靶蛋白 SARS-CoV-2 Mpro 的配体,可用于合成 PROTAC SARS-CoV-2 Mpro degrader-8(MS-M09065)。

Ligand
SARS-CoV-2 Mpro ligand 2

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础